1050 Wishard Blvd.
Jiali Han, PhD, is currently professor and chair, Department of Epidemiology, Richard M. Fairbanks School of Public Health, and Rachel Cecile Efroymson professor of cancer research at Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. Dr. Han earned his PhD in Biological Sciences in Public Health from Harvard University in 2004. He then joined the faculties of Harvard Medical School and the Harvard School of Public Health. Prior to his move to Indianapolis in 2013, he was an associate professor of epidemiology at Harvard School of Public Health, and associate professor of medicine and dermatology at Brigham and Women’s Hospital and Harvard Medical School.
Dr. Han has been the principal investigator on a dozen of NIH grants. He also serves as a key investigator on multiple NIH-funded projects, providing critical expertise in genetic and molecular epidemiology to his collaborators and peers. He has published over 200 original research articles in peer-reviewed journals. A series of his seminal research findings has been published in high-profile journals and drew enormous attention not only from the scientific community but also from public media. Dr. Han has been invited to speak about his research at regional, national, and international scientific meetings. He has served as ad hoc reviewer for over 100 peer-reviewed scientific journals. Dr. Han has served on a number of national and international committees and grant review panels in the NIH study sections, the U.S. Department of Defense, and the American Cancer Society. He has been on several committees and chaired sessions of national and international scientific societies.
Dr. Han has shown tremendous dedication to training and mentorship. He has mentored and co-mentored over 40 graduate students, medical students, fellows, clinicians, and junior faculty members. Many of them have gone on to academic and research careers globally.
Dr. Han leads genetic and molecular epidemiology studies of cancer etiology, prevention, outcome and global health. (1) He has been leading international consortia on genetic susceptibility to keratinocyte carcinoma. Currently, he leads the post-“genome-wide association study” collaborative effort on integrative and functional analysis of genetic variants associated with skin cancer. He has also played a leading role in international collaborative consortia on pigmentary traits, skin and lung cancers. (2) He has studied breast cancer screening strategies. (3) He conducts data science and network research and pharmaco-epidemiology research. (4) Another area of his research interests is the opioid response-mediated addictive behavior of tanning bed usage.